DLA Piper is recognised for its ability to act on complex cross-border transactions, both inbound into Southeast Asia and outbound to key markets such as the US, UK, and Europe, leveraging deep local insight and the firm’s extensive international network. The group is led by Katherine Chew, described as a ‘savvy and thoughtful legal leader’, who is a go-to for local and multinational corporations in pre-acquisitions, pre-closing and corporate reorganisations.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘DLA Piper is a global practice with demonstrated expertise in many fields. The firm has kept up with building ever stronger specialities.’

  • ‘Katherine Chew's demonstrated capabilities extend far beyond Singapore or even the APAC region. She is a savvy and thoughtful legal leader who "gets" the strategic imperatives.' 

  • ‘What sets this firm apart is its deep regional expertise combined with a truly global outlook, making it uniquely positioned to advise on complex cross-border matters with precision and cultural fluency.' 

  • ‘Katherine Chew stands out for her ability to help us navigate difficult and complex negotiations. She is responsive, affable and solution oriented. I can trust that whatever complex matter I hand to her will be deftly handled by her team. ’

  • ‘Deep knowledge, commercial solutions, excellent project management skills, extremely responsive’

  • ‘Katherine Chew is very responsive and has a list of major multinational clients. ’

Key clients

  • Digital Edge Asia
  • INEOS Phenol
  • Bangchak Corporation Public Company Limited
  • Hy24
  • Templewater
  • Storskogen
  • Huntsman
  • GE
  • Surbana Jurong
  • Sylebra Capital
  • Danaher Corporation
  • OCS Group

Work highlights

Advised Hy24 on its strategic equity investment into InterContinental Energy, alongside GIC, totalling USD 115 million.
Acted for Insightsoftware on its acquisition of Singapore-based JustPerform.
Advised Efor Group on the Singapore, Malaysia, and Indonesia aspects of its strategic acquisition of PharmEng Technology.

Practice head

Katherine Chew